Tag Archives: TTD

The Trade Desk (TTD) Sees Strong Trading Volume Following Analyst Upgrade

The Trade Desk Inc (NASDAQ:TTD) saw an uptick in trading volume on Monday after ValuEngine upgraded the stock from a hold rating to a buy rating. 157,515 shares were traded during trading, a decline of 85% from the previous session’s volume of 1,021,773 shares.The stock last traded at $75.78 and had previously closed at $75.61.

Several other analysts have also recently commented on TTD. Needham & Company LLC boosted their price target on The Trade Desk to $75.00 and gave the stock a “buy” rating in a research report on Friday, May 11th. Stifel Nicolaus boosted their price target on The Trade Desk from $69.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, May 11th. Royal Bank of Canada boosted their price target on The Trade Desk to $80.00 and gave the stock an “outperform” rating in a research report on Friday, May 11th. Oppenheimer began coverage on The Trade Desk in a research report on Thursday, May 10th. They set an “outperform” rating and a $66.00 price target for the company. Finally, Piper Jaffray reiterated an “overweight” rating and set a $80.00 price target on shares of The Trade Desk in a research report on Friday, May 11th. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $69.88.

Get The Trade Desk alerts:

In other The Trade Desk news, insider Brian John Stempeck sold 22,500 shares of the business’s stock in a transaction on Thursday, March 22nd. The stock was sold at an average price of $55.33, for a total transaction of $1,244,925.00. Following the transaction, the insider now owns 67,050 shares of the company’s stock, valued at $3,709,876.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey Terry Green sold 9,000 shares of the business’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $56.26, for a total value of $506,340.00. The disclosure for this sale can be found here. Insiders have sold 985,980 shares of company stock worth $57,474,839 in the last three months. 23.54% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company lifted its stake in shares of The Trade Desk by 5.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 19,665 shares of the technology company’s stock valued at $975,000 after purchasing an additional 1,063 shares during the last quarter. Guggenheim Capital LLC lifted its stake in shares of The Trade Desk by 12.2% in the 1st quarter. Guggenheim Capital LLC now owns 11,257 shares of the technology company’s stock valued at $560,000 after purchasing an additional 1,220 shares during the last quarter. Commonwealth Equity Services LLC lifted its stake in shares of The Trade Desk by 15.6% in the 1st quarter. Commonwealth Equity Services LLC now owns 9,739 shares of the technology company’s stock valued at $483,000 after purchasing an additional 1,314 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in shares of The Trade Desk by 129.2% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 2,750 shares of the technology company’s stock valued at $126,000 after purchasing an additional 1,550 shares during the last quarter. Finally, UBS Group AG lifted its stake in shares of The Trade Desk by 5.8% in the 1st quarter. UBS Group AG now owns 28,231 shares of the technology company’s stock valued at $1,400,000 after purchasing an additional 1,551 shares during the last quarter. 70.94% of the stock is currently owned by institutional investors.

The company has a market cap of $3.16 billion, a P/E ratio of 67.41, a price-to-earnings-growth ratio of 2.83 and a beta of 1.92.

The Trade Desk (NASDAQ:TTD) last announced its quarterly earnings results on Thursday, May 10th. The technology company reported $0.34 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.10 by $0.24. The Trade Desk had a return on equity of 24.07% and a net margin of 16.14%. The business had revenue of $85.70 million for the quarter, compared to analyst estimates of $73.25 million. During the same quarter in the prior year, the company posted $0.18 EPS. The company’s quarterly revenue was up 60.5% on a year-over-year basis. sell-side analysts expect that The Trade Desk Inc will post 1.19 EPS for the current year.

The Trade Desk Company Profile

The Trade Desk, Inc, a technology company, provides a self-service omnichannel software platform that enables clients to purchase and manage data-driven digital advertising campaigns in the United States and internationally. The company's platform allows clients to manage integrated advertising campaigns in various advertising channels and formats, including connected TV, mobile, video, audio, display, social, and native on various devices, such as smart TVs, computers, and mobile phones and tablets.

Why The Trade Desk, Noodles & Co., and Regeneron Pharmaceuticals Jumped Today

The stock market finished mixed on Friday, with the Dow Jones Industrial Average gaining ground even as some broader benchmarks finished closer to unchanged for the day. In the absence of major news, investors seemed content to let positive trends from earlier in the week continue to play out, anticipating a favorable end to the first-quarter earnings season and hoping for more progress on the macroeconomic and geopolitical fronts to defuse potential controversies. Some good reports from several corners of the market also helped lift sentiment. The Trade Desk (NASDAQ:TTD), Noodles & Co. (NASDAQ:NDLS), and Regeneron Pharmaceuticals (NASDAQ:REGN) were among the best performers on the day. Here’s why they did so well.

The Trade Desk puts a good spin on its quarter

Shares of The Trade Desk soared more than 43% after the company reported first-quarter earnings. The provider of programmatic advertising services said that its revenue was higher by more than 60% compared to the year-earlier quarter, with adjusted earnings almost doubling from year-ago levels. Dramatic growth in mobile ads, including mobile video and in-app spending, helped lift the company, as did audio and television ad spending. Trade Desk expects to sustain that momentum for the remainder of the year, boosting its guidance for 2018 as a whole. With its fingers on the pulse of the advertising revenue that drives the business models of the majority of companies on the internet, Trade Desk has plenty of opportunity to keep growing.

Blue and white share certificate for the Trade Desk.

Image source: The Trade Desk.

Noodles: Best served hot

Noodles & Company stock jumped 15% in the wake of the company’s first-quarter financial results. The restaurant chain said that revenue fell 5%, with the year-ago decision to close 55 locations having weighed on top-line performance. Comparable-restaurant sales were down a more modest 0.2%, and adjusted net loss per share narrowed by half compared to the first quarter of 2017. Executives believe that the strategic initiatives that the noodle-focused chain has implemented will keep generating positive results toward a full turnaround. Investors have started believing in Noodles again, and if the restaurant chain can get back to positive comps for the full year, it will mark a key victory for Noodles shareholders going forward.

Has Regeneron hit bottom?

Finally, shares of Regeneron Pharmaceuticals climbed 6%. The biotech company has been in the doldrums for nearly a year now, falling more than 40% just since last August, and pressure on the biotech industry more broadly has weighed on Regeneron. Yet today’s move seems like a justified bounce, and those who are bullish on the stock point to potential success from key prospects like Dupixent, which is currently approved for atopic dermatitis treatment and could see indications expand to asthma patients as well. Even after the drop, Regeneron shares are far from cheap, but those who still see plenty of healthy growth might find current the stock price a bit easier to swallow than loftier levels in past years.

Why The Trade Desk, Noodles & Co., and Regeneron Pharmaceuticals Jumped Today

The stock market finished mixed on Friday, with the Dow Jones Industrial Average gaining ground even as some broader benchmarks finished closer to unchanged for the day. In the absence of major news, investors seemed content to let positive trends from earlier in the week continue to play out, anticipating a favorable end to the first-quarter earnings season and hoping for more progress on the macroeconomic and geopolitical fronts to defuse potential controversies. Some good reports from several corners of the market also helped lift sentiment. The Trade Desk (NASDAQ:TTD), Noodles & Co. (NASDAQ:NDLS), and Regeneron Pharmaceuticals (NASDAQ:REGN) were among the best performers on the day. Here’s why they did so well.

The Trade Desk puts a good spin on its quarter

Shares of The Trade Desk soared more than 43% after the company reported first-quarter earnings. The provider of programmatic advertising services said that its revenue was higher by more than 60% compared to the year-earlier quarter, with adjusted earnings almost doubling from year-ago levels. Dramatic growth in mobile ads, including mobile video and in-app spending, helped lift the company, as did audio and television ad spending. Trade Desk expects to sustain that momentum for the remainder of the year, boosting its guidance for 2018 as a whole. With its fingers on the pulse of the advertising revenue that drives the business models of the majority of companies on the internet, Trade Desk has plenty of opportunity to keep growing.

Blue and white share certificate for the Trade Desk.

Image source: The Trade Desk.

Noodles: Best served hot

Noodles & Company stock jumped 15% in the wake of the company’s first-quarter financial results. The restaurant chain said that revenue fell 5%, with the year-ago decision to close 55 locations having weighed on top-line performance. Comparable-restaurant sales were down a more modest 0.2%, and adjusted net loss per share narrowed by half compared to the first quarter of 2017. Executives believe that the strategic initiatives that the noodle-focused chain has implemented will keep generating positive results toward a full turnaround. Investors have started believing in Noodles again, and if the restaurant chain can get back to positive comps for the full year, it will mark a key victory for Noodles shareholders going forward.

Has Regeneron hit bottom?

Finally, shares of Regeneron Pharmaceuticals climbed 6%. The biotech company has been in the doldrums for nearly a year now, falling more than 40% just since last August, and pressure on the biotech industry more broadly has weighed on Regeneron. Yet today’s move seems like a justified bounce, and those who are bullish on the stock point to potential success from key prospects like Dupixent, which is currently approved for atopic dermatitis treatment and could see indications expand to asthma patients as well. Even after the drop, Regeneron shares are far from cheap, but those who still see plenty of healthy growth might find current the stock price a bit easier to swallow than loftier levels in past years.